生物活性 | |||
---|---|---|---|
描述 | PF-06291874, characterized as a powerful, orally administered, non-peptide antagonist of the glucagon receptor, is being researched for its potential application in managing type 2 diabetes mellitus (T2DM)[1].[2]. |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
1.99mL 0.40mL 0.20mL |
9.93mL 1.99mL 0.99mL |
19.86mL 3.97mL 1.99mL |
参考文献 |
---|